How to Reconstitute MOTS-C MOTS-C is a mitochondrial-derived peptide a 16-amino-acid signaling molecule encoded in mitochondrial DNA that regulates metabolic homeostasis through the AMPK pathway
Reports are issued by independent labs after each manufacturing batch

Side Effects and Risks Comparison GLP-1 medication risks: GI side effects (nausea, vomiting, diarrhea) in 20-40% of patients, usually temporary Pancreatitis (rare) Gallbladder disease (uncommon) Thyroid C-cell tumor warning (animal data) No surgical, anesthesia, or hospitalization risk No permanent anatomical changes Gastric bypass risks: Surgical mortality of 0.2-0.5% Complications in 3-10% of patients (anastomotic leaks, blood clots, bleeding, infection) Dumping syndrome (rapid gastric emptying causing nausea, cramping, diarrhea after eating sugary or fatty foods) in 15-50% of patients Nutritional deficiencies (iron, calcium, B12, folate) requiring lifelong supplementation Internal hernias (long-term risk) Marginal ulcers at the surgical connection point Strictures (narrowing) at the connection sites Bowel obstruction (rare but serious long-term risk) Alcohol sensitivity (faster absorption, higher blood levels) Gastric bypass carries meaningfully higher risks than GLP-1 medications

Asantewaa, G
Suitable for vegans Packaging: 100ml Recommended daily dose, 10 drops taken with breakfast